Explainable machine learning model for predicting acute pancreatitis mortality in the intensive care unit

Current prediction models are suboptimal for determining mortality risk in patients with acute pancreatitis (AP); this might be improved by using a machine learning (ML) model. In this study, we aimed to construct an explainable ML model to calculate the risk of mortality in patients with AP admitte...

Full description

Saved in:
Bibliographic Details
Published inBMC gastroenterology Vol. 25; no. 1; pp. 131 - 11
Main Authors Jiang, Meng, Wu, Xiao-peng, Lin, Xing-chen, Li, Chang-li
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 03.03.2025
BioMed Central
BMC
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Current prediction models are suboptimal for determining mortality risk in patients with acute pancreatitis (AP); this might be improved by using a machine learning (ML) model. In this study, we aimed to construct an explainable ML model to calculate the risk of mortality in patients with AP admitted in intensive care unit (ICU) and compared it with existing scoring systems. A gradient-boosting ML (XGBoost) model was developed and externally validated based on two public databases: Medical Information Mart for Intensive Care (MIMIC, training cohort) and the eICU Collaborative Research Database (eICU-CRD, validation cohort). We compared the performance of the XGBoost model with validated clinical risk scoring systems (the APACHE IV, SOFA, and Bedside Index for Severity in Acute Pancreatitis [BISAP]) by area under receiver operating characteristic curve (AUC) analysis. SHAP (SHapley Additive exPlanations) method was applied to provide the explanation behind the prediction outcome. The XGBoost model performed better than the clinical scoring systems in correctly predicting mortality risk of AP patients, achieving an AUC of 0.89 (95% CI: 0.84-0.94). When set the sensitivity at 100% for death prediction, the model had a specificity of 38%, much higher than the APACHE IV, SOFA and BISAP score, which had a specificity of 1%, 16% and 1% respectively. This model might increase identification of very low-risk patients who can be safely monitored in a general ward for management. By making the model explainable, physicians would be able to better understand the reasoning behind the prediction.
AbstractList Current prediction models are suboptimal for determining mortality risk in patients with acute pancreatitis (AP); this might be improved by using a machine learning (ML) model. In this study, we aimed to construct an explainable ML model to calculate the risk of mortality in patients with AP admitted in intensive care unit (ICU) and compared it with existing scoring systems.BACKGROUNDCurrent prediction models are suboptimal for determining mortality risk in patients with acute pancreatitis (AP); this might be improved by using a machine learning (ML) model. In this study, we aimed to construct an explainable ML model to calculate the risk of mortality in patients with AP admitted in intensive care unit (ICU) and compared it with existing scoring systems.A gradient-boosting ML (XGBoost) model was developed and externally validated based on two public databases: Medical Information Mart for Intensive Care (MIMIC, training cohort) and the eICU Collaborative Research Database (eICU-CRD, validation cohort). We compared the performance of the XGBoost model with validated clinical risk scoring systems (the APACHE IV, SOFA, and Bedside Index for Severity in Acute Pancreatitis [BISAP]) by area under receiver operating characteristic curve (AUC) analysis. SHAP (SHapley Additive exPlanations) method was applied to provide the explanation behind the prediction outcome.METHODSA gradient-boosting ML (XGBoost) model was developed and externally validated based on two public databases: Medical Information Mart for Intensive Care (MIMIC, training cohort) and the eICU Collaborative Research Database (eICU-CRD, validation cohort). We compared the performance of the XGBoost model with validated clinical risk scoring systems (the APACHE IV, SOFA, and Bedside Index for Severity in Acute Pancreatitis [BISAP]) by area under receiver operating characteristic curve (AUC) analysis. SHAP (SHapley Additive exPlanations) method was applied to provide the explanation behind the prediction outcome.The XGBoost model performed better than the clinical scoring systems in correctly predicting mortality risk of AP patients, achieving an AUC of 0.89 (95% CI: 0.84-0.94). When set the sensitivity at 100% for death prediction, the model had a specificity of 38%, much higher than the APACHE IV, SOFA and BISAP score, which had a specificity of 1%, 16% and 1% respectively.RESULTSThe XGBoost model performed better than the clinical scoring systems in correctly predicting mortality risk of AP patients, achieving an AUC of 0.89 (95% CI: 0.84-0.94). When set the sensitivity at 100% for death prediction, the model had a specificity of 38%, much higher than the APACHE IV, SOFA and BISAP score, which had a specificity of 1%, 16% and 1% respectively.This model might increase identification of very low-risk patients who can be safely monitored in a general ward for management. By making the model explainable, physicians would be able to better understand the reasoning behind the prediction.CONCLUSIONSThis model might increase identification of very low-risk patients who can be safely monitored in a general ward for management. By making the model explainable, physicians would be able to better understand the reasoning behind the prediction.
Current prediction models are suboptimal for determining mortality risk in patients with acute pancreatitis (AP); this might be improved by using a machine learning (ML) model. In this study, we aimed to construct an explainable ML model to calculate the risk of mortality in patients with AP admitted in intensive care unit (ICU) and compared it with existing scoring systems. A gradient-boosting ML (XGBoost) model was developed and externally validated based on two public databases: Medical Information Mart for Intensive Care (MIMIC, training cohort) and the eICU Collaborative Research Database (eICU-CRD, validation cohort). We compared the performance of the XGBoost model with validated clinical risk scoring systems (the APACHE IV, SOFA, and Bedside Index for Severity in Acute Pancreatitis [BISAP]) by area under receiver operating characteristic curve (AUC) analysis. SHAP (SHapley Additive exPlanations) method was applied to provide the explanation behind the prediction outcome. The XGBoost model performed better than the clinical scoring systems in correctly predicting mortality risk of AP patients, achieving an AUC of 0.89 (95% CI: 0.84-0.94). When set the sensitivity at 100% for death prediction, the model had a specificity of 38%, much higher than the APACHE IV, SOFA and BISAP score, which had a specificity of 1%, 16% and 1% respectively. This model might increase identification of very low-risk patients who can be safely monitored in a general ward for management. By making the model explainable, physicians would be able to better understand the reasoning behind the prediction.
Background Current prediction models are suboptimal for determining mortality risk in patients with acute pancreatitis (AP); this might be improved by using a machine learning (ML) model. In this study, we aimed to construct an explainable ML model to calculate the risk of mortality in patients with AP admitted in intensive care unit (ICU) and compared it with existing scoring systems. Methods A gradient-boosting ML (XGBoost) model was developed and externally validated based on two public databases: Medical Information Mart for Intensive Care (MIMIC, training cohort) and the eICU Collaborative Research Database (eICU-CRD, validation cohort). We compared the performance of the XGBoost model with validated clinical risk scoring systems (the APACHE IV, SOFA, and Bedside Index for Severity in Acute Pancreatitis [BISAP]) by area under receiver operating characteristic curve (AUC) analysis. SHAP (SHapley Additive exPlanations) method was applied to provide the explanation behind the prediction outcome. Results The XGBoost model performed better than the clinical scoring systems in correctly predicting mortality risk of AP patients, achieving an AUC of 0.89 (95% CI: 0.84-0.94). When set the sensitivity at 100% for death prediction, the model had a specificity of 38%, much higher than the APACHE IV, SOFA and BISAP score, which had a specificity of 1%, 16% and 1% respectively. Conclusions This model might increase identification of very low-risk patients who can be safely monitored in a general ward for management. By making the model explainable, physicians would be able to better understand the reasoning behind the prediction. Keywords: Acute pancreatitis, Prognostic factor, XGBoost, Mortality, Prediction
BackgroundCurrent prediction models are suboptimal for determining mortality risk in patients with acute pancreatitis (AP); this might be improved by using a machine learning (ML) model. In this study, we aimed to construct an explainable ML model to calculate the risk of mortality in patients with AP admitted in intensive care unit (ICU) and compared it with existing scoring systems.MethodsA gradient-boosting ML (XGBoost) model was developed and externally validated based on two public databases: Medical Information Mart for Intensive Care (MIMIC, training cohort) and the eICU Collaborative Research Database (eICU-CRD, validation cohort). We compared the performance of the XGBoost model with validated clinical risk scoring systems (the APACHE IV, SOFA, and Bedside Index for Severity in Acute Pancreatitis [BISAP]) by area under receiver operating characteristic curve (AUC) analysis. SHAP (SHapley Additive exPlanations) method was applied to provide the explanation behind the prediction outcome.ResultsThe XGBoost model performed better than the clinical scoring systems in correctly predicting mortality risk of AP patients, achieving an AUC of 0.89 (95% CI: 0.84–0.94). When set the sensitivity at 100% for death prediction, the model had a specificity of 38%, much higher than the APACHE IV, SOFA and BISAP score, which had a specificity of 1%, 16% and 1% respectively.ConclusionsThis model might increase identification of very low-risk patients who can be safely monitored in a general ward for management. By making the model explainable, physicians would be able to better understand the reasoning behind the prediction.
Abstract Background Current prediction models are suboptimal for determining mortality risk in patients with acute pancreatitis (AP); this might be improved by using a machine learning (ML) model. In this study, we aimed to construct an explainable ML model to calculate the risk of mortality in patients with AP admitted in intensive care unit (ICU) and compared it with existing scoring systems. Methods A gradient-boosting ML (XGBoost) model was developed and externally validated based on two public databases: Medical Information Mart for Intensive Care (MIMIC, training cohort) and the eICU Collaborative Research Database (eICU-CRD, validation cohort). We compared the performance of the XGBoost model with validated clinical risk scoring systems (the APACHE IV, SOFA, and Bedside Index for Severity in Acute Pancreatitis [BISAP]) by area under receiver operating characteristic curve (AUC) analysis. SHAP (SHapley Additive exPlanations) method was applied to provide the explanation behind the prediction outcome. Results The XGBoost model performed better than the clinical scoring systems in correctly predicting mortality risk of AP patients, achieving an AUC of 0.89 (95% CI: 0.84–0.94). When set the sensitivity at 100% for death prediction, the model had a specificity of 38%, much higher than the APACHE IV, SOFA and BISAP score, which had a specificity of 1%, 16% and 1% respectively. Conclusions This model might increase identification of very low-risk patients who can be safely monitored in a general ward for management. By making the model explainable, physicians would be able to better understand the reasoning behind the prediction.
Current prediction models are suboptimal for determining mortality risk in patients with acute pancreatitis (AP); this might be improved by using a machine learning (ML) model. In this study, we aimed to construct an explainable ML model to calculate the risk of mortality in patients with AP admitted in intensive care unit (ICU) and compared it with existing scoring systems. A gradient-boosting ML (XGBoost) model was developed and externally validated based on two public databases: Medical Information Mart for Intensive Care (MIMIC, training cohort) and the eICU Collaborative Research Database (eICU-CRD, validation cohort). We compared the performance of the XGBoost model with validated clinical risk scoring systems (the APACHE IV, SOFA, and Bedside Index for Severity in Acute Pancreatitis [BISAP]) by area under receiver operating characteristic curve (AUC) analysis. SHAP (SHapley Additive exPlanations) method was applied to provide the explanation behind the prediction outcome. The XGBoost model performed better than the clinical scoring systems in correctly predicting mortality risk of AP patients, achieving an AUC of 0.89 (95% CI: 0.84-0.94). When set the sensitivity at 100% for death prediction, the model had a specificity of 38%, much higher than the APACHE IV, SOFA and BISAP score, which had a specificity of 1%, 16% and 1% respectively. This model might increase identification of very low-risk patients who can be safely monitored in a general ward for management. By making the model explainable, physicians would be able to better understand the reasoning behind the prediction.
ArticleNumber 131
Audience Academic
Author Jiang, Meng
Wu, Xiao-peng
Li, Chang-li
Lin, Xing-chen
Author_xml – sequence: 1
  givenname: Meng
  surname: Jiang
  fullname: Jiang, Meng
– sequence: 2
  givenname: Xiao-peng
  surname: Wu
  fullname: Wu, Xiao-peng
– sequence: 3
  givenname: Xing-chen
  surname: Lin
  fullname: Lin, Xing-chen
– sequence: 4
  givenname: Chang-li
  surname: Li
  fullname: Li, Chang-li
BackLink https://www.ncbi.nlm.nih.gov/pubmed/40033198$$D View this record in MEDLINE/PubMed
BookMark eNptkkFv3CAQha0qVZNs-wd6qCz10otTMGDwqYqiJI0UqZdW6g2N8XiXlQ1bwFHy74uzaZqtKg6Dho8HD95pceS8w6J4T8kZpar5HGmtZFORWlSEyZpV7FVxQrmkVc3Iz6MX8-PiNMYtIVSqmr0pjjkhjNFWnRT28n43gnXQjVhOYDbWYTkiBGfdupx8j2M5-FDuAvbWpKUJZk5Y7sCZgJBssjFzIcFo00NpXZk2mEtCF-0dlgYClrOz6W3xeoAx4runuip-XF1-v_ha3X67vrk4v60M5yJVkjBsSMe4UpR22ZegPSBpGQFEppQybaOGoZad4ANpByZAYCs6kNgbxJ6tipu9bu9hq3fBThAetAerHxs-rDWEZM2ImqPqKOVgBuw4FQ3wBjpomOzbtu2VyFpf9lq7uZsWfZcCjAeihyvObvTa3-n8P1K2-dar4tOTQvC_ZoxJTzYaHEdw6OeoGZWMk4bLJqMf_0G3fg4uv9VCifxnioq_1BqyA-sGnw82i6g-V3UrRC34onX2HyqPHidrcowGm_sHGz68dPps8U9SMlDvARN8jAGHZ4SSxW6j93HUOY76MY6asd-S59JX
Cites_doi 10.1046/j.0007-1323.2001.02025.x
10.1159/000090032
10.1016/j.gie.2010.10.006
10.2307/2531595
10.1186/s12876-019-1016-y
10.1155/2021/5525118
10.1136/gut.2008.152702
10.1136/bmj.g7594
10.1145/2939672.2939785
10.1053/j.gastro.2007.03.065
10.1053/j.gastro.2019.09.009
10.7326/M16-0650
10.1186/s12876-021-01906-2
10.1136/gutjnl-2012-302779
10.1016/S0140-6736(20)31310-6
10.14309/ajg.0000000000000632
10.1186/s13017-019-0247-0
10.1016/j.pan.2013.07.063
10.1007/s10115-013-0679-x
10.1002/bjs.1800771120
10.1016/0022-4804(77)90045-2
ContentType Journal Article
Copyright 2025. The Author(s).
COPYRIGHT 2025 BioMed Central Ltd.
2025. This work is licensed under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
The Author(s) 2025 2025
Copyright_xml – notice: 2025. The Author(s).
– notice: COPYRIGHT 2025 BioMed Central Ltd.
– notice: 2025. This work is licensed under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: The Author(s) 2025 2025
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7QP
7QR
7T5
7X7
7XB
88E
8FD
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FR3
FYUFA
GHDGH
H94
K9.
M0S
M1P
P64
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.1186/s12876-025-03723-3
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Calcium & Calcified Tissue Abstracts
Chemoreception Abstracts
Immunology Abstracts
Health & Medical Collection (ProQuest)
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Technology Research Database
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central Database Suite (ProQuest)
ProQuest One
ProQuest Central Korea
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
Medical Database
Biotechnology and BioEngineering Abstracts
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
Technology Research Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central China
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
AIDS and Cancer Research Abstracts
Chemoreception Abstracts
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
Immunology Abstracts
Engineering Research Database
ProQuest One Academic
Calcium & Calcified Tissue Abstracts
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic


Publicly Available Content Database

MEDLINE
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ - Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1471-230X
EndPage 11
ExternalDocumentID oai_doaj_org_article_4e8b114acfeb4156a46aba637d999d85
PMC11877909
A829552546
40033198
10_1186_s12876_025_03723_3
Genre Journal Article
GeographicLocations China
GeographicLocations_xml – name: China
GrantInformation_xml – fundername: Fundamental Research Funds for the Central Universities
  grantid: 2022ZFJH003
– fundername: National Natural Science Foundation of China
  grantid: 82000478
– fundername: Natural Science Foundation of Zhejiang Province
  grantid: LMS25H180003
GroupedDBID ---
0R~
23N
2WC
53G
5VS
6J9
6PF
7X7
88E
8FI
8FJ
AAFWJ
AAJSJ
AASML
AAWTL
AAYXX
ABDBF
ABUWG
ACGFO
ACGFS
ACIHN
ACIWK
ACPRK
ACUHS
ADBBV
ADRAZ
ADUKV
AEAQA
AENEX
AFKRA
AFPKN
AHBYD
AHMBA
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C6C
CCPQU
CITATION
CS3
DIK
E3Z
EAD
EAP
EAS
EBD
EBLON
EBS
EMB
EMK
EMOBN
ESX
F5P
FYUFA
GROUPED_DOAJ
GX1
HMCUK
HYE
IAO
IHR
INH
INR
ITC
KQ8
M1P
M~E
O5R
O5S
OK1
OVT
P2P
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
RBZ
RNS
ROL
RPM
RSV
SMD
SOJ
SV3
TR2
TUS
UKHRP
W2D
WOQ
WOW
XSB
CGR
CUY
CVF
ECM
EIF
NPM
PMFND
3V.
7QP
7QR
7T5
7XB
8FD
8FK
AZQEC
DWQXO
FR3
H94
K9.
M48
P64
PJZUB
PKEHL
PPXIY
PQEST
PQUKI
PRINS
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c445t-703e60b348811b03751dae0930aee3888c968ff27b54f09f35a5e95ba7edceed3
IEDL.DBID 7X7
ISSN 1471-230X
IngestDate Wed Aug 27 01:09:42 EDT 2025
Thu Aug 21 18:27:15 EDT 2025
Fri Jul 11 07:01:35 EDT 2025
Fri Jul 25 21:28:35 EDT 2025
Tue Jun 17 22:00:28 EDT 2025
Tue Jun 10 21:08:31 EDT 2025
Mon May 12 02:38:51 EDT 2025
Tue Jul 01 05:18:59 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Prognostic factor
Acute pancreatitis
Mortality
XGBoost
Prediction
Language English
License 2025. The Author(s).
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c445t-703e60b348811b03751dae0930aee3888c968ff27b54f09f35a5e95ba7edceed3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink https://www.proquest.com/docview/3175400815?pq-origsite=%requestingapplication%
PMID 40033198
PQID 3175400815
PQPubID 44673
PageCount 11
ParticipantIDs doaj_primary_oai_doaj_org_article_4e8b114acfeb4156a46aba637d999d85
pubmedcentral_primary_oai_pubmedcentral_nih_gov_11877909
proquest_miscellaneous_3173406476
proquest_journals_3175400815
gale_infotracmisc_A829552546
gale_infotracacademiconefile_A829552546
pubmed_primary_40033198
crossref_primary_10_1186_s12876_025_03723_3
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2025-03-03
PublicationDateYYYYMMDD 2025-03-03
PublicationDate_xml – month: 03
  year: 2025
  text: 2025-03-03
  day: 03
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle BMC gastroenterology
PublicationTitleAlternate BMC Gastroenterol
PublicationYear 2025
Publisher BioMed Central Ltd
BioMed Central
BMC
Publisher_xml – name: BioMed Central Ltd
– name: BioMed Central
– name: BMC
References C Li (3723_CR1) 2021; 21
Q Qiu (3723_CR10) 2019; 19
3723_CR9
CB Pearce (3723_CR11) 2006; 6
A Leppäniemi (3723_CR23) 2019; 14
3723_CR24
3723_CR22
C Wilson (3723_CR6) 1990; 77
GS Collins (3723_CR12) 2015; 350
F Deshmukh (3723_CR16) 2020; 115
L Boxhoorn (3723_CR2) 2020; 396
E Strumbelj (3723_CR25) 2014; 41
M Motwani (3723_CR13) 2017; 38
PA Banks (3723_CR4) 2013; 62
CE Forsmark (3723_CR21) 2007; 132
3723_CR18
JH Ranson (3723_CR7) 1977; 22
A Buter (3723_CR3) 2002; 89
MY Di (3723_CR5) 2016; 165
3723_CR17
DL Shung (3723_CR15) 2020; 158
F Pedregosa (3723_CR19) 2011; 12
ER DeLong (3723_CR20) 1988; 44
G Rotondano (3723_CR14) 2011; 73
BU Wu (3723_CR8) 2008; 57
References_xml – volume: 89
  start-page: 298
  issue: 3
  year: 2002
  ident: 3723_CR3
  publication-title: Brit J Surg
  doi: 10.1046/j.0007-1323.2001.02025.x
– volume: 6
  start-page: 123
  issue: 1–2
  year: 2006
  ident: 3723_CR11
  publication-title: Pancreatology
  doi: 10.1159/000090032
– volume: 73
  start-page: 218
  issue: 2
  year: 2011
  ident: 3723_CR14
  publication-title: Gastrointest Endosc
  doi: 10.1016/j.gie.2010.10.006
– volume: 44
  start-page: 837
  issue: 3
  year: 1988
  ident: 3723_CR20
  publication-title: Biometrics
  doi: 10.2307/2531595
– volume: 19
  start-page: 118
  issue: 1
  year: 2019
  ident: 3723_CR10
  publication-title: BMC Gastroenterol
  doi: 10.1186/s12876-019-1016-y
– ident: 3723_CR9
  doi: 10.1155/2021/5525118
– volume: 57
  start-page: 1698
  issue: 12
  year: 2008
  ident: 3723_CR8
  publication-title: Gut
  doi: 10.1136/gut.2008.152702
– volume: 350
  start-page: g7594
  year: 2015
  ident: 3723_CR12
  publication-title: BMJ
  doi: 10.1136/bmj.g7594
– ident: 3723_CR18
– ident: 3723_CR24
– ident: 3723_CR17
  doi: 10.1145/2939672.2939785
– volume: 132
  start-page: 2022
  issue: 5
  year: 2007
  ident: 3723_CR21
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2007.03.065
– volume: 38
  start-page: 500
  issue: 7
  year: 2017
  ident: 3723_CR13
  publication-title: Eur Heart J
– volume: 158
  start-page: 160
  issue: 1
  year: 2020
  ident: 3723_CR15
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2019.09.009
– volume: 165
  start-page: 482
  issue: 7
  year: 2016
  ident: 3723_CR5
  publication-title: Ann Intern Med
  doi: 10.7326/M16-0650
– volume: 12
  start-page: 2825
  year: 2011
  ident: 3723_CR19
  publication-title: JMLR
– volume: 21
  start-page: 332
  issue: 1
  year: 2021
  ident: 3723_CR1
  publication-title: BMC Gastroenterol
  doi: 10.1186/s12876-021-01906-2
– volume: 62
  start-page: 102
  issue: 1
  year: 2013
  ident: 3723_CR4
  publication-title: Gut
  doi: 10.1136/gutjnl-2012-302779
– volume: 396
  start-page: 726
  issue: 10252
  year: 2020
  ident: 3723_CR2
  publication-title: Lancet
  doi: 10.1016/S0140-6736(20)31310-6
– volume: 115
  start-page: 1657
  issue: 10
  year: 2020
  ident: 3723_CR16
  publication-title: Am J Gastroenterol
  doi: 10.14309/ajg.0000000000000632
– volume: 14
  start-page: 27
  year: 2019
  ident: 3723_CR23
  publication-title: World J Emerg Surg
  doi: 10.1186/s13017-019-0247-0
– ident: 3723_CR22
  doi: 10.1016/j.pan.2013.07.063
– volume: 41
  start-page: 647
  year: 2014
  ident: 3723_CR25
  publication-title: Knowl Inf Syst
  doi: 10.1007/s10115-013-0679-x
– volume: 77
  start-page: 1260
  issue: 11
  year: 1990
  ident: 3723_CR6
  publication-title: Brit J Surg
  doi: 10.1002/bjs.1800771120
– volume: 22
  start-page: 79
  issue: 2
  year: 1977
  ident: 3723_CR7
  publication-title: J Surg Res
  doi: 10.1016/0022-4804(77)90045-2
SSID ssj0017823
Score 2.3974879
Snippet Current prediction models are suboptimal for determining mortality risk in patients with acute pancreatitis (AP); this might be improved by using a machine...
Background Current prediction models are suboptimal for determining mortality risk in patients with acute pancreatitis (AP); this might be improved by using a...
BackgroundCurrent prediction models are suboptimal for determining mortality risk in patients with acute pancreatitis (AP); this might be improved by using a...
Abstract Background Current prediction models are suboptimal for determining mortality risk in patients with acute pancreatitis (AP); this might be improved by...
SourceID doaj
pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage 131
SubjectTerms Acute Disease
Acute pancreatitis
Adult
Aged
Algorithms
Analysis
APACHE
Care and treatment
China
Clinical medicine
Datasets
Development and progression
Female
Forecasts and trends
Health aspects
Hospital Mortality
Humans
Intensive care
Intensive Care Units
Learning algorithms
Machine Learning
Male
Medical research
Medicine, Experimental
Methods
Middle Aged
Missing data
Mortality
Online databases
Pancreatitis
Pancreatitis - mortality
Patient admissions
Patients
Prediction
Prediction models
Prevention
Prognosis
Prognostic factor
Risk Assessment - methods
Risk groups
ROC Curve
Severity of Illness Index
Triage (Medicine)
Vital signs
XGBoost
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9wwEBYlh5JLadq02TQtKgR6KCa29T4mpSEU0lMCuQlJllof4oSs9_93RpaXNTnkUvDJGj-kmdF8Y8-DkNPgTSOciZXLKTmoikbrUHHGA0tKCePwg_71b3l1y3_dibudVl8YEzaVB54W7oxH7QGzu5CiR2fDcem8k0x1AG06nauXgs2bnany_wDsHptTZLQ8W8MurDDYVlQ1Uy2r2MIM5Wr9z_fkHaO0DJjcsUCXb8mbAh3p-fTKB-RVHN6R19fl5_h70mM8XUmGovc5SDLS0hXiD80tbyhAVPr4hJdguDN1YTNGChvChB3Hfg10iMcBm9N-oIAOaT8HuVOMEqMb2AMOye3lz5sfV1XppFAFzsVYgVpHWXsG2to0HtveNp2LtWG1i5GBExyM1Cm1ygueapOYcCIa4Z3COceOfSB7w8MQjwgFByTJTrKUYges5S6Bh-U6mYxsdafYinyfF9Y-TgUzbHY0tLQTGyywwWY2WKC-wLXfUmKx63wCRMAWEbAvicCKfEPOWVRJYE9wJbMAXhiLW9lz3RohsPD_ipwsKEGVwnJ45r0tqry2CLA4Iid4ztftMF6J4WlDfNhkGsYxbRdu8XESle2UOLbLa4xeEb0QosWclyND_zcX-sZW8MrU5vh_rNInst9OCgDHCdkbnzbxMwCq0X_JuvMP51UejA
  priority: 102
  providerName: Directory of Open Access Journals
Title Explainable machine learning model for predicting acute pancreatitis mortality in the intensive care unit
URI https://www.ncbi.nlm.nih.gov/pubmed/40033198
https://www.proquest.com/docview/3175400815
https://www.proquest.com/docview/3173406476
https://pubmed.ncbi.nlm.nih.gov/PMC11877909
https://doaj.org/article/4e8b114acfeb4156a46aba637d999d85
Volume 25
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1La9wwEBZtAqWX0nc3TRcVCj0UE9t6n0q2JIRCQgkNLL0I2ZYSH-rd7nr_f2ZkeRtTKBgfrLGxPJqX_M0MIZ_qyhTCGZ-5mJKDomi0rjPOeM2CUsI43NC_vJIXN_z7UizThts2wSpHnRgVdbOqcY_8BO0cRwMmvq7_ZNg1Cv-uphYaj8khli5DSJda7gOuAqwfGxNltDzZgi5WCLkVWc5UyTI2MUaxZv-_mvmBaZrCJh_YofPn5FlyIOnpwPEX5JHvXpInl-kX-SvSIqoupUTR3xEq6WnqDXFLY-MbCo4qXW_wFgQ9U1fvek9BLQweZN9ugQ69cvDQadtR8BFpO0LdKWLF6A40wWtyc37289tFlvopZDXnos9AuL3MKwYyWxQVNr8tGudzw3LnPYNQuDZSh1CqSvCQm8CEE96Iyimcs2_YG3LQrTr_jlAIQ4JsJAvBN8Bg7gLEWa6RwchSN4rNyJfxw9r1UDbDxnBDSzuwwQIbbGSDBeoFfvs9JZa8jhdWm1ubJMhyrysI3lwdfIVRp-PSVU4y1YCP22gxI5-RcxYFE9hTu5RfAC-MJa7sqS6NEFj-f0aOJ5QgUPV0eOS9TQK9tX-X34x83A_jnQhS6_xqF2kYx-RdeMTbYansp8SxaV5h9IzoySKazHk60rV3sdw3NoRXJjdH_3-v9-RpOSxtOI7JQb_Z-Q_gMPXVPErFnBwuzq5-XM_jtgOcrxe_7gGLsRkX
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VrQRcEG8CBYwE4oCi7saP2AeEWmi1pd0VQq3Um-skdsmB7LIPIf4Uv5GZPJZGSNwq5RRPXp7nF894AF7nmRlJZ3zs6pIcUkWjdR4LLnIe0lQaRz_0J1M1PhOfz-X5FvzuamEorbKzibWhLmY5_SPfJT8nyIHJD_MfMXWNotXVroVGIxbH_tdPhGzL90efkL9vkuTw4PTjOG67CsS5EHIVo4h7Ncw4Su5olFEL2FHhPAL7ofOeIyDMjdIhJGkmRRiawKWT3sjMpZQw6QuO970B24IjlBnA9v7B9MvXzboF-lveleZotbtE659Skq-M8UEJj3nP_dVdAv71BVecYT9R84rnO7wLd9qQle01MnYPtnx1H25O2kX5B1BSHl9bhMW-18mZnrXdKC5Z3WqHYWjM5gu6hNKsmcvXK8_QEDUx66pcIh3hAMQErKwYRqWs7JLrGWWnsTXanodwdi1z_QgG1azyT4Ah8AmqUDwEX6BICRcQ2blCBaMSXaQ8gnfdxNp5s1GHrQGOVrZhg0U22JoNFqn3ae43lLTJdn1itri0rc5a4XWGcNHlwWeEc51QLnOKpwVG1YWWEbwlzlkyBcie3LUVDfjCtKmW3dOJkZIaDkSw06NEFc77wx3vbWtClvavwEfwajNMV1JaXOVn65qGCyoXxls8bkRl80mC2vSNjI5A94So9839kar8Vm8wTi3oUzM0T___Xi_h1vh0cmJPjqbHz-B20og5HjswWC3W_jmGa6vsRasjDC6uWy3_AE5WU_o
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Explainable+machine+learning+model+for+predicting+acute+pancreatitis+mortality+in+the+intensive+care+unit&rft.jtitle=BMC+gastroenterology&rft.au=Jiang%2C+Meng&rft.au=Xiao-peng%2C+Wu&rft.au=Xing-chen%2C+Lin&rft.au=Chang-li%2C+Li&rft.date=2025-03-03&rft.pub=BioMed+Central&rft.eissn=1471-230X&rft.volume=25&rft.spage=1&rft_id=info:doi/10.1186%2Fs12876-025-03723-3
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-230X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-230X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-230X&client=summon